Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: My Laymans Take ...

"IMO, the court gave the plaintiffs a break, allowing them time to take stock of the situation, consider the probable outcomes of the remaining issues, and act accordingly before the loss is magnified further. "

That's the reason we won't see a PR until things have cleared.
IMO the plaintiffs have to consider if they can afford to continue.
I'm sure there have been a lot of discussions and negotiations behind the doors in the last months/weeks between our side and the T3 - we don't know what has happened, especially in the last 36 hours.

I expect the company to have a plan if all ducks are in a row, but IMO the last ducks are refusing to line up accordingly...:-)

GLTA

Share
New Message
Please login to post a reply